Requests · Department of State Health Services
Address the Projected Texas HIV Medication Program Shortfall
Priority 5 · one of 6 items in the Department of State Health Services's request for 2028-29 · The item begins on page 336 of the request
This is a request, not an appropriation.
What is asked
| 2028 | 2029 | Two years | |
|---|---|---|---|
| All funds | $34,482,412 | $34,482,412 | $68,964,824 |
| Of which general revenue and general revenue-dedicated | $34,482,412 | $34,482,412 | $68,964,824 |
| Positions (full-time equivalents) | — | — |
How it would be financed
| Method of financing, as the request prints it | 2028 | 2029 |
|---|---|---|
| 1 General Revenue Fund | $34,482,412 | $34,482,412 |
| Total, as the request prints it | $34,482,412 | $34,482,412 |
Where it would land
The strategies this item would add to, numbered as the request numbers them, beside what each is appropriated in the current budget (2026-27 Act). One column is an appropriation and the other a request made on top of a base request not shown here, so the two are not subtracted.
| Strategy | Asked 2028 | Asked 2029 | Positions | Appropriated 2026 | Appropriated 2027 |
|---|---|---|---|---|---|
| 01-02-02 HIV/STD PreventionIn the current budget: A.2.2 HIV/STD PREVENTION | $34,482,412 | $34,482,412 | — | $232,874,181 | $231,042,860 |
A strategy is matched by its name. Where none is matched, the strategy may be new, or may be in the current budget under a different name.
After 2029
| The agency's estimate | 2030 | 2031 | 2032 | Three years |
|---|---|---|---|---|
| All funds | $34,482,412 | $34,482,412 | $34,482,412 | $103,447,236 |
| Of which general revenue | $34,482,412 | $34,482,412 | $34,482,412 | $103,447,236 |
In the agency's words: Continue providing medications to THMP eligible clients.
The agency's justification
• THMP Shortfall: $69.0M over the biennium in General Revenue funds to continue serving qualified, low-income Texans living with HIV under the Texas HIV Medication Program.
External and internal factors
The Texas Department of State Health Services (DSHS) projects a Texas HIV Medication Program (THMP) budget shortfall beginning FY 2027. This program provides life-saving medications to nearly 23,000 low-income Texans living with HIV and allows people with HIV to live longer, healthier lives, while reducing the risk of transmission to others.
In recent years, the THMP has become increasingly unstable due to federal policy changes, increased client rolls, reduced drug manufacturer rebate revenue, and rising medication costs. In particular, these changes impact the AIDS Drug Assistance Program (ADAP) portion of the program, which is based on a direct medication purchase model.
ADAP enrollment has increased from 18,560 individuals in FY 2019 to a total anticipated 22,655 clients in FY 2026. At the same time, total medication expenditures increased from $113.3 million in FY 2019 to a projected $135.6 million in FY 2026. Projected program costs continue to increase, with expected expenditures outpacing incoming funds in FY 2027.
To help address this budget imbalance, DSHS is working to implement an Insurance First model in THMP. This means that DSHS will seek to move clients from the higher-cost ADAP direct medication purchase model to TIAP-Plus, the insurance purchase portion of THMP that is less costly and generates more rebate revenue to support the program. However, DSHS still needs both supplemental funding for FY 2027 and exceptional item funding in FY 2028-2029 to serve THMP clients under current eligibility standards.
Without additional funding, DSHS would need to change eligibility standards that would significantly reduce the number of individuals served by THMP . The daily medications and support provided by THMP are critical to clients’ health, stability, and ability to remain virally suppressed. Additional funding would ensure uninterrupted access to medications for eligible Texans who rely on the program.
As marked in the request
- Has an information technology part: No
- Costs anticipated after the two budget years: Yes
- Involves contracts over $50,000: Yes